Abdi İbrahim across the globe
Abdi İbrahim is strengthening its position on the international stage, with exports to more than 70 countries.
Growing strength in the international arena
The company is growing at a sustainable pace, applying various strategic business models under both its own brand and its customers’ brands in the regions where it operates.
The company continues to grow in Albania, Algeria, Azerbaijan, Bosnia and Herzegovina, Georgia, Germany, Iraq, Italy, Kazakhstan, Kosovo, Kyrgyzstan, Morocco, North Macedonia, Saudi Arabia, Serbia, Tunisia, the UAE, the UK and Uzbekistan thanks to Abdi İbrahim-branded products and its own sales and marketing organisations.
With its own teams abroad, Abdi İbrahim benefits from a broad portfolio of Abdi İbrahim-branded and customer-branded products in markets around the world, including Europe and Canada. Licensing sales worldwide contribute to steady growth in the company’s exports.
Developing markets
In addition to its own sales and marketing teams in several countries, Abdi İbrahim works with local distributors in developing markets. They bring Abdi İbrahim products to patients in many regions and raise brand recognition with new products. The company also follows pharmaceutical market dynamics closely in order to seize new opportunities quickly.
In line with its strategic goals to 2025 and its aim of becoming a global player, the company has focused on expanding its presence in developing markets. Abdi İbrahim is developing new business models for countries where it is already present but does not yet have its own sales and marketing teams, as well as strategies for entering new markets.
The company aims to strengthen its position above all in the Gulf (GCC) countries, the CIS, the Balkans, Asia-Pacific and Latin America.
Developed markets
As the largest player in the Turkish pharmaceutical industry, Abdi İbrahim exports to 70 countries through out-licensing, distributors and joint product development with leading pharmaceutical companies.
European-standard products manufactured at its EU GMP-certified plant in Istanbul are also supplied through its Portuguese subsidiary Abdi Farma.
Abdi İbrahim out-licenses products in Europe, Canada and Australia, sells Abdi Farma products through distributors in several European countries and continues joint development of new medicines with leading global pharmaceutical companies.
Expanding international collaboration
Abdi İbrahim’s international operations cover North Africa, Central Asia, Europe, the Middle East, the Caucasus and North America (Canada). Using various business models, the company steadily increases its exports to more than 70 countries and expands its presence in both developed and developing markets.
Helping more people every day through exports to more than 70 countries.